CSPC is one of few drugmakers in China to receive global approvals for Covid-19 mRNA vaccines and the first to roll out in the world's second-most populous country, which has a rapidly ageing society. CSPC plans to launch an RSV shot in 2026.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3nB16oU
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment